Ann: Fully-Funded Trial Approved In Germany, page-6

well the announcement is price sensitive but it doesn't provide any material information... IMO.

it doesn't tell you how long the trial will continue, it doesn't say how many patients roughly will be there and hence hard to say it was a buy announcement... IMO.

people who invested in past trials only to find out that those trials are of no use to TGA or even other places for reimbursement, probably get's hint not to get too emotional to the stock ... IMO.

They couldn't sell anything in EU after 2 year (almost) since CE approval and all they got is approval for trials (yes fully funded is positive part of it) but where does it take possibility of selling it in UK or Greece or France or Switzerland or Italy or Spain ? will they need to do more trials to prove it again before selling? they couldn't find a single private patient in EU over last 2 years (almost) so how they will do it now? IMO these are some serious questions and only company can answer them... !

so lot's of questions still requires investor confidence in my opinion... !